Regenerative medicine

Stem Cell Therapy for the Shoulder and Rotator Cuff: What the Studies Show

Stem cell therapy for the shoulder usually means concentrating cells from your own bone marrow or fat and placing them in the rotator cuff, either during surgery or by injection. The strongest trial found fewer repeat tears after surgical repair but no better pain or function, injection trials are small and early, and there are no human studies for frozen shoulder.

By Dr. Jesse Morse · November 17, 2026

THIS NOTICE MUST BE PROVIDED TO YOU UNDER FLORIDA LAW. This physician performs one or more stem cell therapies that have not yet been approved by the United States Food and Drug Administration. You are encouraged to consult with your primary care provider before undergoing any stem cell therapy.

What stem cell therapy for the shoulder involves

In orthopedics, “stem cell therapy” almost always means one of two same-day procedures using your own tissue:

  • Bone marrow aspirate concentrate (BMAC). Marrow is drawn from the back of the hip under local anesthetic, spun in a centrifuge, and the concentrate is injected. Read what BMAC is for the details.
  • Fat-derived cells. A small amount of fat is taken from the abdomen or flank and processed to release its cells.

The cells go to the shoulder in one of two ways. A surgeon can apply them at the repair site during rotator cuff surgery, or a physician can inject them into a tendon, bursa or joint under ultrasound without surgery. The two approaches have very different evidence, so it helps to know which one a clinic is offering. For the background, read what stem cell therapy is.

What the studies show

Here is where each shoulder use stands:

UseEvidenceWhat it found
Added during rotator cuff repairTwo randomized trials (91 and 93 patients). Meta-analysis of 5 studies, 415 patientsFewer repeat tears on MRI; pain and function no better than repair alone
Injection for a partial tear or tendinopathySmall trials (16 to 51 patients), mostly run by device makers or clinicsEncouraging early results; no large sham-controlled trial published
Shoulder osteoarthritisOne pilot randomized trial, 25 shoulders, stopped earlyNo difference on the main outcome versus cortisone
Frozen shoulderNo human studiesUnknown
Compared with PRPNo head-to-head randomized trial in the shoulderAdding BMAC to PRP during surgery: no extra benefit at 6 months

During rotator cuff repair surgery

Repaired rotator cuff tendons often tear again, and bone marrow cells were first tried as a way to help the tendon heal back to the bone. In a 2014 French study, 45 patients who received bone marrow concentrate during repair were compared with 45 matched patients who did not. At ten years, 87% of the treated group still had an intact cuff, against 44% of the controls. The study was not randomized, which limits how much weight it can carry. A 2017 Korean study matched 35 patients given fat-derived cells during repair with 35 who were not: repeat tears were 14% against 29%, with no difference in pain or function.

The best test so far is a 2023 randomized trial from Rush University in 91 patients with a 1 to 3 cm supraspinatus tear. Every patient had a repair, and the control group had a sham incision at the hip so they could not tell which group they were in. At one year, MRI showed a repeat tear in 18% of the bone marrow group and 57% of the controls. Yet pain and shoulder function scores at two years were no better in the bone marrow group, and treatment failure, meaning scores worse than before surgery or a further operation, occurred in 7 patients in each group. In the authors' words, the cells gave a structurally better repair but largely failed to improve how the shoulder felt or worked.

A 2025 meta-analysis of five studies and 415 patients found the same pattern: a repeat tear rate of 18% with stem cells against 35% without, and similar pain, motion and function. A separate 2025 review rated the certainty of that benefit as limited. In a 2026 randomized trial of large 3 to 5 cm tears, adding bone marrow concentrate to PRP during repair made no difference at six months.

Injections for partial tears and tendinopathy

This is what most clinics offer, and the evidence is earlier:

  • A Korean first-in-human trial injected cultured fat-derived cells into partial tears in 20 patients, with no comparison group. Pain and function scores improved by about 80% in the higher dose groups, MRI showed the defects shrinking, and there were no treatment-related adverse events through two years. Under federal rules, cultured (lab-grown) cells like these can be given in the U.S. only under FDA authorization, normally a clinical trial.
  • A 2020 U.S. pilot randomized 20 patients with partial tears to fat-derived cells or a steroid injection, and 16 were analyzed. The cell group scored higher at six and twelve months, and a 2023 follow-up found the difference held at about three years. Most authors were tied to the device maker. A larger trial by the same company, with 168 patients, finished its main data collection in 2023 and has not posted results.
  • A 2024 trial from a bone marrow clinic network randomized 51 patients with high-grade partial or full supraspinatus tears to bone marrow concentrate plus platelet products, or home exercise. The injection group did better at three months on pain and function, and most patients with repeat MRIs showed some healing. There was no placebo injection, the exercise group could switch to injections after three months, and the authors work for the network.

These results are encouraging enough to justify a proper trial, and none of them is that trial yet. Each was small, none used a placebo injection, and most were run by the people selling the treatment.

Shoulder arthritis

A Canadian pilot trial compared bone marrow aspirate (not concentrated) with cortisone in 25 arthritic shoulders. It was stopped early when Canadian rules changed, and its main outcome showed no clear difference at twelve months, though three secondary scores favored the bone marrow group. A 2025 review of shoulder arthritis injections concluded that the evidence for orthobiologics remains limited.

Frozen shoulder

I could not find a single human study of stem cells for frozen shoulder; the published work is in rats, mostly with stem cell-derived vesicles rather than whole cells. If a clinic offers stem cells for frozen shoulder, ask what evidence they are relying on. PRP has been tested against a steroid in frozen shoulder, which I cover in PRP shoulder injections.

What the evidence adds up to

Bone marrow cells seem to help a repaired tendon stay attached, and that has not yet translated into a shoulder that feels or works better in the first two years. For injections without surgery, the early numbers look good and the trials are too small and too close to their sponsors to settle the question. Any clinic that promises a stem cell injection will regrow a torn rotator cuff is claiming more than the research shows.

Stem cells vs. PRP for the shoulder

No randomized trial has compared bone marrow concentrate head to head with PRP in the shoulder, and in a 2026 trial adding it to PRP during repair gave no extra benefit. No shoulder guideline recommends bone marrow concentrate. PRP has more shoulder trials behind it, needs only a blood draw, and costs less, so it is usually the first biologic to consider. Bone marrow concentrate is sometimes considered when PRP and a full course of rehab have not been enough. For the PRP evidence by condition, read PRP shoulder injections: what the studies show.

Who might be a candidate

A stem cell procedure is worth discussing when:

  • The diagnosis is confirmed, usually a partial rotator cuff tear or tendinopathy seen on MRI or ultrasound
  • Several months of structured rehab have not resolved it
  • PRP or a steroid injection has been tried or is not a good fit
  • You understand the evidence is early and are paying out of pocket

It is the wrong first step for a large full-thickness tear in an active person, or for sudden weakness after an injury. Those need a surgical opinion, and if you have surgery, cell augmentation is a question for your surgeon.

What to expect from the procedure

  1. Diagnosis. A shoulder exam, a review of your MRI, and usually an ultrasound in the office to confirm the tear or tendon problem.
  2. Harvest. For bone marrow concentrate, you lie face down and marrow is drawn from the back of the hip through a needle under local anesthetic. It is then concentrated in a centrifuge.
  3. Injection. The concentrate is placed into the tendon, bursa or joint under ultrasound guidance.
  4. Recovery. The hip and shoulder are sore for several days. Gentle movement starts early, and a rehab program runs for six to twelve weeks.

The visit takes two to three hours. Most people return to desk work within a few days, and to overhead sport or heavy lifting over several months, guided by how the shoulder responds.

Risks and side effects

In the injection trials above, no serious treatment-related adverse events were reported. The usual side effects are pain at the hip and shoulder for several days, bruising and stiffness. Infection and nerve injury at the harvest site are rare. The larger risks come from donor products of unknown origin, which can be contaminated during processing or not tested for infections. Your own cells, processed the same day and placed with ultrasound, carry a different risk profile.

How much it costs

I am not aware of a published average for the shoulder. The best-known published figure is for the knee: researchers posing as patients found U.S. clinics quoted $5,156 on average for one knee. Shoulder procedures are priced per area, and ultrasound guidance can add to the cost. Insurance generally does not pay. For what drives the price, read how much stem cell therapy costs.

Questions to ask before stem cell therapy for your shoulder

  1. What exactly is wrong with my shoulder, and how was that confirmed?
  2. Where do the cells come from: my bone marrow, my fat, or a donor product?
  3. Is the injection guided by ultrasound, and where will it go?
  4. Have I done enough rehab, and should I try PRP first?
  5. What does the published evidence show for my diagnosis specifically?
  6. What is the total cost, including imaging and follow-up?

Shoulder evaluations with me in Miami

My practice focuses on non-surgical orthopedics, including rotator cuff problems. Every plan starts with the diagnosis: a hands-on exam, your imaging and, when it helps, an ultrasound in the clinic. For most shoulders the right first steps are rehab or PRP. If a bone marrow procedure is reasonable for you, you get the evidence for your diagnosis and the price before treatment, an ultrasound-guided injection at The Osteopathic Center, and a rehab plan to go with it. If you need a surgeon, I will tell you.

My online consultations are $300 for 30 minutes and $600 for 60 minutes, for patients located in Florida or Tennessee. See stem cell therapy in Miami, or book a consultation.

Frequently asked questions

Does stem cell therapy work for the shoulder?

The best evidence is for adding bone marrow cells during rotator cuff repair surgery. There it lowers the rate of repeat tears on MRI, but pain and function come out about the same as surgery alone. For injections without surgery, the published trials are small and early, and no large sham-controlled trial has been published.

Can stem cells heal a torn rotator cuff without surgery?

There is no good evidence that an injection closes a full-thickness tear. For partial tears, small trials of bone marrow and fat-derived cells reported better pain and function scores and some healing on MRI, but they had few patients, no placebo arm, and most were run by the companies or clinics offering the treatment.

Is stem cell therapy better than PRP for the shoulder?

No randomized trial has compared them directly in the shoulder. In a 2026 trial of large rotator cuff repairs, adding bone marrow concentrate to PRP gave no extra benefit at six months. PRP has more shoulder trials and costs less, so it is usually considered first.

Can stem cells help a frozen shoulder?

I am not aware of any human study of stem cells for frozen shoulder. The only published work is in rats. PRP and steroid injections have been tested in people, and frozen shoulder often improves on its own, though it can take one to three years.

Does stem cell therapy help shoulder arthritis?

The evidence is thin. A small randomized trial comparing bone marrow aspirate with cortisone was stopped early and found no difference on its main outcome, though three secondary scores favored the bone marrow group. A 2025 review called orthobiologic evidence for shoulder arthritis limited.

How long is recovery after a stem cell shoulder injection?

The hip, where marrow is drawn, and the shoulder are usually sore for several days. Most people return to desk work within a few days and follow a rehab program for six to twelve weeks. When it helps, improvement builds over weeks to months.

How much does stem cell therapy for the shoulder cost?

I am not aware of a published average for the shoulder. The best-known published figure is for the knee, where researchers posing as patients found U.S. clinics quoted $5,156 on average for one knee. Shoulder prices vary by clinic and by whether ultrasound guidance is used, and insurance generally does not pay.

Is stem cell therapy for the shoulder FDA-approved?

No. No stem cell product is FDA-approved for any shoulder condition. Same-day bone marrow aspirate concentrate usually relies on a federal exception for tissue returned to the same patient during the same procedure, and Florida law allows certain other unapproved stem cell therapies in orthopedics under strict conditions.

Sources

THIS NOTICE MUST BE PROVIDED TO YOU UNDER FLORIDA LAW. This physician performs one or more stem cell therapies that have not yet been approved by the United States Food and Drug Administration. You are encouraged to consult with your primary care provider before undergoing any stem cell therapy.